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Abstract
Mammary stem cells (MaSCs) play essential roles for the development of the mammary gland and its remodeling during
pregnancy. However, the precise localization of MaSCs in the mammary gland and their regulation during pregnancy is
unknown. Here we report a transgenic mouse model for luciferase-based single marker detection of MaSCs in vivo that we
used to address these issues. Single transgene expressing mammary epithelial cells were shown to reconstitute mammary
glands in vivo while immunohistochemical staining identified MaSCs in basal and luminal locations, with preponderance
towards the basal position. By quantifying luciferase expression using bioluminescent imaging, we were able to track MaSCs
non-invasively in individual mice over time. Using this model to monitor MaSC dynamics throughout pregnancy, we found
that MaSCs expand in both total number and percentage during pregnancy and then drop down to or below baseline levels
after weaning. However, in a second round of pregnancy, this expansion was not as extensive. These findings validate a
powerful system for the analysis of MaSC dynamics in vivo, which will facilitate future characterization of MaSCs during
mammary gland development and breast cancer.
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Introduction
The mammary gland is a highly dynamic organ, undergoing
well choreographed growth and involution during development,
estrous cycles, and pregnancy [1,2]. In pubertal mice, a structure
named the terminal end bud invades into the empty mammary
stroma, also known as the mammary fat pad. Once fully
developed, the mammary gland forms a ductal tree structure
composed of branches with hollow lumens capped at the ends by
secretory acinar structures. During pregnancy, the mammary
epithelium expands extensively, filling in much of the mammary
fat pad, and then undergoes involution after weaning to return to a
state similar to the pre-pregnant gland. The mammary gland is
composed of two primary cell types: luminal epithelial and
myoepithelial cells. Luminal epithelial cells line the inside of the
ducts and are believed to be derived from the inner body cells of
the terminal end bud. A subset of these luminal cells is responsible
for secreting milk during pregnancy. Contractile myoepithelial
cells on the other hand are believed to be derived from the outer
cap cells of the terminal end bud and exist on the external layer of
the ducts. Despite many years of research, the identity of the
mouse mammary epithelial stem cell (MaSC), capable of
differentiating into these cell types and responsible for gland
formation and remodeling, was not elucidated until recently [3,4].
Using fluorescence activated cell sorting (FACS) and mammary
fat pad transplantation experiments, MaSC-enriched populations
were identified by the expression of CD24 along with high
expression of either CD29 or CD49f [3,4]. Subsequent research
has just begun to elucidate what governs MaSCs growth and
differentiation as well as how MaSCs function in the mammary
gland [5,6,7,8]. Studying MaSC regulation in vivo is critical for
understanding stem cell-niche interactions in the mammary gland
and investigating the potential link between MaSC activity and
breast cancer susceptibility. Unfortunately, the high degree of
precision in detecting protein level variations using FACS cannot
be achieved in immunostaining and thus has made it difficult to
localize MaSCs by immunostaining of surface markers in
combination. Furthermore, even after definitive identification of
MaSCs, the only currently available method to monitor their
dynamics was to use flow cytometry after dissecting mammary
glands, making it impossible to monitor MaSCs in individual mice
over time.
In order to overcome these difficulties, we have characterized a
novel mouse model for in vivo MaSC tracking based on our
discovery that MaSC-enriched cells from a luciferase/GFP-
transgenic mouse strain [9] are the only mammary epithelial cell
type with appreciable transgene expression. Single cells, sorted
based solely on the expression of the transgene were able to
repopulate mammary glands in vivo. By monitoring luciferase
expression in recipient mice, we were able to quantitatively track
the regulation of MaSCs in individual mice non-invasively using
bioluminescence imaging (BLI). Additionally, the restricted
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e8035expression of luciferase allowed us to precisely identify the location
of MaSC-enriched epithelial populations in the mammary gland
using immunohistochemistry.
Results
Restricted Luciferase Expression in Functional MaSCs
When comparing the relative luciferase expression in different
organs from transgenic mice designed to express luciferase and GFP
under the control of the CMV enhancer/b-actin promoter [9], the
mammary gland showed significantly lower expression of luciferase
than other organs from the same mouse (Fig. 1A, B). After dissociating
the gland into a single cell suspension and sorting using either of the





hi)[ 3 , 4 ] ,,15–25 fold higher expression of luciferase was
observed in the MaSCs compared to the other mammary epithelial
populations (Fig. 1C–G) which mirrored the levels of luciferase mRNA
(Fig. 1H). This restricted pattern of luciferase expression is stable
across many generations of mice.
In order to test whether the luciferase expressing MaSC enriched
populationspossessed functional stem cellactivityinvivo,w ep e rf o rm ed




hi surface marker profile, the MaSC-enriched




lo) and other mammary epithelial cells
(Lin
2CD24
2) were sorted from luciferase transgenic mice and
transplanted into non-transgenic mammary fat pads cleared of their
endogenous epithelium. Luciferase expression, which expanded
quickly within the first two weeks after transplantation before reaching
a relative steady state, was detected solely in the mice receiving
CD24
+CD29
hi cells (Fig. 2A). Representative images of recipient mice
are shown in Fig. 2B, along with alum carmine staining of the
transplanted mammary fat pads. Of critical importance is that
whenever luciferase expression was detected in recipient mice,
mammary gland reconstitution was also observed (Fig. 2B - orange
arrow), indicative of functional in vivo stem cell activity.
Because not every cell in the FACS-sorted populations (Fig. 1C,
D) isa MaSC,thepossibilityarose thattheluciferaseexpressing cells
within these MaSC-enriched populations may be distinct from the
functional MaSC population. To address this, we sought to test the
reconstitution ability of single luciferase expressing cells. However,
since FACS is unable to sort live cells based on the expression of
luciferase, we investigated whether the luciferase expressing
CD24
+CD29
hi cells also expressed any detectable GFP. Even
though the bulk of the mammary gland, like other tissues from the
adult transgenic mouse [9], did not show much GFP signal, we saw
a small but distinct GFP signal in the CD24
+CD29
hi population
(Fig. 3A). By sorting Lin
2 cells solely based on the GFP expression,
luciferase expression was highly restricted to the GFP
hi subpopu-
lation (Fig. 3B). To definitively show that the luciferase/GFP
expressing cells were functional stem cells, single visualized GFP
hi
cells were transplanted into cleared mammary fat pads. In 4 of 52
transplants, mammary gland reconstitution was observed (Fig. 3C,
D), which is a similar rate to published cell surface markers [3].
Additionally, by transplanting 500 GFP
hi and 4000 or 10,000 GFP
lo
cells, we observed that MaSC activity was highly enriched in the
GFP
hi population (Fig. S1). Based on these results, we are confident
that luciferase expression could indeed serve as a single, robust
marker forMaSC activity both in vivoand in situto addressbiological
questions concerning the regulation and localization of MaSCs.
Immunohistochemical Localization of MaSCs
By performing immunohistochemical staining against the
luciferase protein, we were able to clearly localize the MaSC-
enriched cells within the mammary gland (Fig. 4). In 12-week-old
nulliparous mice, luciferase expressing cells were seen in two
distinct locations: a basal position between the myoepithelial and
luminal epithelial compartments (Fig. 4A–C, red arrows), and a
luminal position (Fig. 4A–C, black arrows). Among the 9.0% of
luciferase expressing cells, 6.3% of the cells were located in the
basal position while 2.7% percent were in the luminal position.
While the presence of luciferase expressing cells in the luminal
position was initially unexpected, it is interesting to note that
CD29 deletion from the basal compartment of the mammary
gland was recently found to ablate a significant amount of MaSC
function, but did not prevent the formation of secretory acinar
structures during pregnancy [11], suggesting the possibility of a
distinct stem/progenitor population outside the basal layer. This is
also consistent with the finding that in the MaSC-enriched fraction
isolated by CD24 and CD49f, there was a subpopulation of cells
which expressed the luminal marker Keratin 18 [4]. When
mammary glands from younger transgenic mice are stained (,3
weeks old), an overall higher number of luciferase-positive MaSC-
enriched cells is observed, both in the cap and ductal regions of the
terminal end buds (Fig. 4E, F)
Importantly, when luciferase expressing MaSCs isolated by
CD24
+CD29
hi or GFP expression are transplanted they differen-
tiate into mostly non-luciferase expressing mammary epithelial
cells (Fig. 2) as they reconstitute the mammary gland. The
reconstituted mammary glands show similar numbers of luciferase
positive and negative cells to glands of transgenic mice (Fig. 4G–I).
Thus, by tracking luciferase dynamics in vivo rather than in situ,w e
are confident we can monitor MaSC activity in real time during
physiologically relevant processes.
Dynamics of MaSCs throughout Pregnancy
The major function of the mammary gland is to supply milk
during nursing. In order to perform this function, the gland
undergoes a massive expansion to generate secretory structures to
produce milk. The regulation of this expansion was believed to be
due to stem cell activity, but this has not been shown directly.
Previous studies have attempted to quantify the overall change in
the number of MaSCs after pregnancy [12,13]. However, these
studies only looked at one time point well after pups were weaned
and showed differing results based on the age of mice. To further
investigate the activity of MaSCs during the entire course of
pregnancy, two to three weeks after luciferase expressing MaSCs
were transplanted into fat pads of 3 week old mice cleared of their
endogenous epithelium (at which point their activity reaches a
relative steady state – see Fig. 2A), we induced pregnancy and
monitored luciferase activity to detect MaSC dynamics. On
average, MaSC activity rose roughly 200 fold during pregnancy
and began to drop back down immediately after the pups were
born, eventually returning close to baseline levels around the time
that pups are weaned (Fig. 5 A,B). This effect is clearly dependent
on the mother nursing their young pups, as MaSC numbers drop
precipitously if the pups are separated right after birth (Fig. 5, ‘‘No
Nursing’’ group).
We also monitored MaSC regulation using the traditional flow
cytometry method (which quantifies the changes in percentage of
cells within the mammary gland rather than total number) by
sacrificing mice at each individual time point throughout the
pregnancy cycle. Comparing the two methods allowed us to asses
the possibility that the expansion and regression in the number of
MaSCs observed in vivo by BLI may simply correlated with the
changes in the gland as a whole, since the mammary gland
expands extensively in response to pregnancy and involutes after
weaning. We observed a similar expansion and regression of
Mammary Stem Cell Dynamics
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expansion proceeded in a faster rate than the gland as a whole.
Using flow cytometry also permitted us to quantify the changes in









lo cells both rose and fell with a delayed
kinetics following the expansion and regression of CD24
+CD29
hi
cells, indicating that these cells may be direct progenies of
Figure 1. Luciferase activity from the mammary glands of a luciferase-transgenic mouse is restricted to mammary stem cells. (A)
Representative bioluminescence (BLI) images of FVB-N/J control and luciferase transgenic mice. (B) BLI images of individual organs from luciferase
transgenic animals. Luciferase activity is largely absent from the mammary glands of luciferase transgenic mice. Abbreviations: M.G., mammary gland;
Per., peritoneum; Kid., kidney; Int., intestine; Sto., stomach. (C,D) Mammary glands were dissociated and stained with CD24 and either CD29 (C)o r
CD49f (D) (MRU: Mammary Repopulating Unit, equivalent to MaSC; CFC: Colony Forming Cells; MYO: Myoepithelial cells) before subjecting to flow
cytometry analysis and sorting. (E, F) Sorted MaSCs showed elevated luciferase expression compared to other mammary epithelial populations (data
normalized to the luciferase activity of unsorted mammary epithelial populations +/2 SEM). (G) Representative BLI images of sorted populations
based on CD24 and CD29 staining. (H) qRT-PCR analysis of luciferase mRNA levels (+/2 SEM) normalized to the levels of a-tubulin.
doi:10.1371/journal.pone.0008035.g001
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+CD29
hi cells as has been suggested elsewhere [14]. The
number of CD24
+CD29
lo cells also dropped precipitously when
mothers did not nurse their pups (Fig. 5C). As CD24
+CD29
lo cells
have been shown to contain lactogenic precursors, it is not
surprising that their expansion is observed after pregnancy, during
nursing.
To better observe the morphological changes associated with
the massive expansion of MaSC activity, we performed immuno-
staining of luciferase transgenic mammary glands throughout
pregnancy (Fig. 6). While it is clear that the number of luciferase
expressing cells rises in both the alveolar buds and the mature
ducts during pregnancy, precise quantification of the changes in
cell numbers was difficult because of the weakening of gap
junctions that typically occurs during pregnancy, which results in
comparatively diffuse staining [1]. After pups are separated from
their mothers, the number of luciferase positive cells in the
mammary gland returns back to similar levels of age matched
virgin controls.
While we clearly observed an expansion of luciferase positive
cells, and in the number of CD24
+CD29
hi cells, this did not prove
that the expansion was the result of an actual increase of MaSCs,
since it could also be due to the expansion of another luciferase
expressing cell population within the CD24
+CD29
hi population.
To address this, we first performed luciferase assays on sorted
mammary epithelial cells from the luciferase transgenic mice just
after giving birth to pups (near the peak in both number and
percentage of MaSCs) and observed a restricted pattern of
luciferase expression in CD24
+CD29
hi MaSCs similar to virgin
controls (Fig. S2). Additionally, we performed mammary fat pad
reconstitution assays with CD24
+CD29
hi cells from pregnant and
virgin mice at a limited dilution (500 cells) where we expected not
every mouse would show reconstitution. If the parity related rise in
CD24
+CD29
hi luciferase expressing cells were the result of an
expansion of a non-MaSC population, we would expect to see less
reconstitution when transplanting the same number of cells from
pregnant and virgin mice. However, we observed similar levels of
reconstitution (57.1% for pregnant, n=7 and 55.6% for virgin,
n=9) suggesting that the rise in luciferase expressing
CD24
+CD29
hicells was indeed a rise in MaSCs.
In order to better understand the regulations of MaSCs during
pregnancy, we also assessed the regulation of MaSCs throughout a
second round of pregnancy using both flow cytometry and the BLI
methods (Fig. 7). Because tissue collection for flow cytometry
requires sacrificing of donor mice, averages must be compared
from different mice across pregnancies. Our non-invasive model
has the advantage of being able to monitor the kinetics in
individual mice throughout successive pregnancies. Overall there
was a moderate reduction in the peak amount of MaSCs during
the second pregnancy when normalized to plug date, which was
evident in both our in vivo model (Fig. 7A) and using flow
cytometry (Fig. 7B). The number of MaSCs returned back to
similar levels after weaning of pups.
Discussion
The isolation of mouse MaSCs capable of forming a functional
mammary gland from a single cell has opened up many new
avenues of research to study the function and regulation of these
cells. These avenues will diverge down many paths, from studying
the role of MaSCs in mammary gland development, to
understanding the regulation of self renewal and differentiation
of MaSCs, to investigating a potential role of MaSC in breast
tumorigenesis. Recent studies have begun to unveil the complex
nature of MaSC regulation. For example, CD29 (b1 integrin) and
Figure 2. Luciferase activity correlates with in vivo stem cell
activity. (A) 1000 mammary epithelial cells of the indicated population
were transplanted into mammary fat pads cleared of their endogenous
epithelium and subsequent BLI intensity was quantified in individual
mice over 12 weeks, normalized to the time of injection. (B)
Representative BLI images (left panel) and alum carmine staining of
mammary glands (right panel) 12 weeks after transplantation of various
mammary epithelial cell populations into cleared fat pads. Luciferase
activity was detected solely in mice receiving CD24
+CD29
hi MaSCs (P4)
and not in mice receiving CD24
+CD29
lo (P5) and CD24
2 P6 cells (middle
and lower panel). Mice with strong luciferase activity showed mammary
gland reconstitution, based on alum carmine staining (arrow).
doi:10.1371/journal.pone.0008035.g002
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function [11,15], while the differentiation of MaSCs has been
shown to be influenced by the transcription factor GATA-3 [14]
and Notch signaling [7,8]. Furthermore, the growth of MaSCs is
likely to be directly regulated by epidermal growth factor via
binding to EGFR/ErbB1 but only indirectly by estrogen or
progesterone since they do not express their respective receptors
[5,6]. Despite these recent advances, better methods to sensitively
and non-invasively monitor MaSC activity in vivo are urgently
needed to facilitate future study of MaSC function and regulation.
The model we have presented in this study will be a valuable
research platform in the characterization of MaSCs since it is the
only tool available for quantitative real-time tracking of MaSC-
enriched cells in living animals. Few if any other adult stem cell
models allow for both single marker histological analysis of adult
stem cell localization and the ability to monitor adult stem cell
activity in individual mice over time. Our model represents a
significantly simplified surrogate to the more cumbersome FACS
methods which can not be used to assess MaSC activity
longitudinally in living animals and requires a large number of
animals to obtain data at different time points of the experiment.
Using this model in combination with immunohistochemistry, we
have identified the location of luciferase expressing MaSCs in both
a luminal and basal compartment. Future characterization will
help to elucidate whether these two epithelial populations are
functionally distinct from one another. Furthermore, this model
can be coupled with genetic manipulations of MaSCs in vivo or ex
vivo [16] prior to transplantation or with manipulation of the host
microenvironment to study how MaSCs are regulated by intrinsic
signaling pathways or extrinsic cues from their surrounding niche.
Figure 3. GFP positive cells can reconstitute a mammary gland. (A) Flow cytometry analysis of GFP expression in the indicated mammary
epithelial populations based on CD24 and CD29 staining in wild type (red) and luciferase transgenic (green) mice. A noticeable shift in the
CD24
+CD29
hi (P4) population in GFP expression is observed (second panel), which accounts for the small GFP
hi shoulder in the unsorted cells (first
panel). (B) When GFP
hi and GFP
lo cells are collected and tested for luciferase expression, luciferase activity is largely restricted to the GFP
hi population.
(C) Confirmation of single cell reconstitution of the mammary gland by alum carmine staining of the mammary gland in 4 of 52 recipient mice. (D) BLI
images of a representative mouse after receiving transplantation of a single GFP
hi.
doi:10.1371/journal.pone.0008035.g003
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throughout pregnancy, where we have shown that MaSCs rise in
both total number and percentage during pregnancy and then decline
to or below baseline levels after weaning. This effect is dampened when
mothers do not nurse their young. Additionally, the magnitude of
MaSC expansion is decreased during a second pregnancy. These
results are particularly interesting when considered in the context of
breast cancer, as it is known that in both mice and humans, full-term
and multiple pregnancy results in a short term increase, but ultimately
a long term decrease in breast cancer susceptibility [17]. It has been
proposed that this is due to the transient expansion of MaSCs during
pregnancyand their depletion afterwards, as MaSCs or progenitorcells
may serve as the particularly susceptible cellular targets for
transformation. Curiously, this protective effect is weakened when
mothers do not nurse their young. Future studies should directly test
the susceptibility of MaSCs to transformation to better understand how
changes in their cell number throughout pregnancy may alter the
likelihood of developing breast cancer.
In summary, our model serves as a unique platform in which
MaSC activity can be non-invasively, sensitively and quantitatively
monitored by bioluminescence imaging. This system will not only
allow for the monitoring of MaSC activity in normal physiolog-
ically relevant processes but will also permit more direct evaluation
of the susceptibility of MaSCs to oncogenic transformation and the
regulation of their growth throughout tumorigenesis. If MaSCs
play a critical role in the initiation or progression of breast cancer,
this model will serve as an ideal system to develop and test future
therapeutic applications that target MaSCs, including potentially
novel prophylactic breast cancer treatments for high risk groups.
Materials and Methods
Animal Studies
All experiments involving mice were performed in accordance
with approved protocols by the Institutional Animal Care and Use
Committee of Princeton University. FVB/N-J mice were pur-
chased from The Jackson Laboratory, FVB/N-Luciferase trans-
genic mouse strain L2G85 [9] were a gift of Dr. Chirstopher
Contag and Dr. Yu-an Cao.
Mammary Epithelial Cell Preparation and FACS
Single cell suspensions were prepared from the mammary glands
of luciferase transgenic animals after mechanical and enzymatic
dissociation based on published protocols [3,4]. Briefly, mammary
glands were excised, minced using scalpels, and digested for 1hr in
300U/ml type 1A collagenase (Sigma) and 100U/ml hyaluronidase
(Sigma). Cells were then treated with 0.25% trypsin/EDTA, dispase
(Invitrogen)/DNase (Sigma), and ammonium chloride in succession.
Figure 4. Localization of luciferase expressing MaSCs in the mammary gland. (A–C) Immunohistochemical staining of 4mm paraffin
sections of mammary glands from a 12-week-old luciferase transgenic mouse. Luciferase expressing MaSCs are observed in two locations: a basal
position, indicated by red arrows, and a luminal position, indicated by black arrows. (D) Control staining of luciferase in non-transgenic mouse. (E,F)
Staining of 3-week-old luciferase transgenic mouse mammary glands revealed an increased number of luciferase expressing MaSCs in terminal end
buds. (G–I) Reconstituted glands from 1000 sorted CD24
+CD29
hi P4 cells (G) singe GFP
+ (H) or 500 GFP
+ (I) sorted cells all showed that the luciferase
expressing transplanted cells were found to differentiate into non-luciferase expressing cells as they reconstitute the gland. Scale bar in (A)
represents 20mm. All panels in this figure use the same scale.
doi:10.1371/journal.pone.0008035.g004
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PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8035Figure 5. Mammary epithelial cell dynamics throughout pregnancy. (A) Average (+/2 SEM) of luciferase activity in five pregnant (blue) and
seven virgin (red) mice after cleared fat pad injections (FPI) where endogenous epithelium was removed prior to transplantation. A separate group of
seven mice which did not nurse their pups are represented in green. Day 0 represents the day that mice in the pregnancy group were plugged, and
the days that pups were born and weaned are highlighted by the blue bars. (B) Representative BLI images of mice from the pregnant, virgin, and no
nursing groups. (C) The kinetics of MaSCs (P4), progenitors (P5) and other epithelial cells (P6) in pregnant (blue) and virgin (red) mice was detected
using flow cytometry. Mice that did not nurse their pups are again shown in green. Each data point represents the average percentage of each
population of the total mammary epithelium from four to six mice per experimental group. (D) Representative flow cytometry analysis results of
various mammary epithelial populations in mice from the pregnant, virgin and no nursing groups at different time points of the experiment. The
reconstitution ability of P4 cells from virgin and pregnant mice around the peak in number of P4 cells during pregnancy is roughly equal as
highlighted by the black arrow.
doi:10.1371/journal.pone.0008035.g005
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DMEM:F12 Ham supplemented with 5mg/ml insulin, 500ng/ml
hydrocortisone, 10ng/ml EGF, 20ng/ml cholera toxin, 5% bovine
calf serum, and 16penicillin/streptomycin). Afterwards, cells were
resuspended in FACS buffer (PBS supplemented with 5% newborn
calf serum plus 16 penicillin/streptomycin) and filtered twice
through 40mm nylon cell strainers. The following antibodies were
used to label cells: biotin conjugated anti-TER119 (red blood cells,
BD cat#553672), biotin conjugated anti-CD31 (endothelial cells, BD
cat#558737), biotin conjugated anti-CD45 (hematopoietic cells, BD
cat#553078), CD29-FITC (Serotec, cat#MCA2298F), CD49f-
FITC (BD cat#555736) and CD24-PE (BD cat#553262). Allophy-
cocyanin (APC) conjugated Streptavidin (BD cat#554067) was used
for secondary staining of lineage markers. For all staining, 50mlo f
antibody diluted 1:75 in FACS buffer was used per 1610
6 cells,
including single color controls and combination staining. Control
samples for triple color FACS included no-staining, propidium iodide
(PI, cell viability dye) only, CD24-PE only, CD29-FITC only, Biotin-
lineage only as well as corresponding PE, FITC and APC single color
fluorochrome conjugated antibody isotype controls. Both primary
and secondary staining was conducted for 30 minutes at room
temperature in FACS buffer. Between staining, cells were washed
with 5ml FACS buffer. Cell sorting for transplantation experiments
was done using a FACSVantage SE w/DiVa (BD Biosciences),
whereas flow cytometric analysis of mammary epithelial cell
populations during pregnancy was performed on a four color, dual-
laser FACSort instrument (BD Biosciences). All cells were sorted into
1:1 Fetal Bovine Serum:MEGM.
In Vitro Luciferase Assays
Sorted cells were centrifuged for 5 minutes at 1000g and then
resuspended in 16 lysis buffer and incubated for 1hr at room
temperature. Substrate was added and luciferase was detected
using a GLOMAX microplate reader and a firefly luciferase assay
kit (Promega). All samples were assayed in triplicate.
qRT-PCR Analysis
RNA was isolated from sorted mammary epithelial populations
using the Trizol (Invitrogen) and contaminating DNA was removed
using the Ambion DNA-free kit. cDNA synthesis was performed using
the Superscript III First-Strand Synthesis System for RT-PCR
(Invitrogen). qRT-PCR was run on an ABI 7900 96 well machine
using the PowerSYBR Green PCR Master Mix from Applied
Biosystems. Samples were run in duplicate using the following primers:
Tubulin Forward: CCTTCATTGGAAACAGCACA, Tubulin Re-
verse: CCTCCTCTCCGAAATCCTCT; Actin Forward: GTATC-
CATGAAATAAGTGGTTACAGG,A c t i nReverse: GCAGTACA-
TAATTTACACAGAAGCAAT,L u c i f e r a s eForward: ATCACAGAA-
TCGTCGTATGC, Luciferase Reverse: GAAATCCCTGGTAATC-
CGTT
Mammary Fat Pad Transplantation and Bioluminescent
Imaging
After FACS, cells were centrifuged for 5 minutes at 1000g and
then resuspended in 50% Matrigel/50% PBS. Mice were
anesthetized by intraperitoneal injection of ketamine (100mg/Kg)
Figure 6. Luciferase immunohistochemistry of parous glands. Mammary glands were taken from pregnant mice midway through their first
pregnancy, at the end of the nursing of their pups, and roughly one month after pups were weaned as well as from age matched virgin controls.
Strong luciferase staining can be seen both in the alveolar bunches of the parous glands, as well as in the ductal regions and in the milk (black arrow).
After pups are weaned, the amount of luciferase expressing MaSCs returns back to similar levels as aged matched virgin controls. Scale bar represents
20mm.
doi:10.1371/journal.pone.0008035.g006
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involved placing 1000 sorted mammary epithelial cells into cleared
inguinal (#4) mammary fat pads according to standard injection
procedures [10]. For single cell injections, cells live cells were
detected using trypan blue staining and visualized in 10ml Terasaki
wells prior to injection. Weekly bioluminescent imaging was done
by injecting anesthetized mice with 100ml of luciferin solution
(15mg/ml) through the orbital plexus. Luciferase activity was
measured in vivo using the Xenogen IVIS 200 imaging system.
Alum Carmine Staining of Mammary Glands
Excised mammary glands were fixed for 1 hour in 3:1 glacial
acetic acid: 100% ethanol, washed in 70% ethanol for 15 minutes
and stained in alum carmine overnight at room temperature.
Glands were then washed for 15 minutes in 70%, 95% and 100%
ethanol and transferred for long term storage into HistocClear II
clearing agent (National Diagnostics).
Immunostaining
Histology services were performed by the Histopathology
Core Facility at Brigham and Women’s Hospital. Formalin
fixed paraffin embedded mammary glands were sectioned
(4mm), incubated at 58uC for 1 hour and then deparaffinized
and rehydrated by washing in twice in xylene, 100% ethanol,
95% ethanol and dH2O. Antigen retrieval was performed using
a pressure cooker (Biocare Medical) at peak temperature of
125uC with EDTA, pH 8. Slides were washed with Tris buffer
with Tween-20 before applying peroxidase block (Dako) for
5m i n u t e s ,r i n s i n gw i t h1 6 Tris, and bathing in serum-free
protein block (Dako) for 20 minutes. Primary staining against
luciferase was done with 1:5000 to 1:10000 diluted Novus goat
polyclonal anti-firefly luciferase antibody (NB100-677) in Dako
Antibody diluent for 1 hour followed by secondary staining with
1:500 diluted rabbit anti-goat (Dako) for 30 min. Slides were
then treated with Dako envision anti-rabbit for 30 min,
and then treated with DAB before counterstaining with
hematoxylin.
Supporting Information
Figure S1 Enriched MaSC activity in GFPhi cells. (A) 500
GFP
hi cells were injected into 16 recipient mice while 4000 or
10,000 GFP
lo cells were injected into 8 mice per group. BLI
activity was subsequently measured over six weeks and normalized
to the signal at the time of injection. (B) Reconstitution ability was
highly enriched in the GFP
hi fraction, with successful reconstitu-
tion (green dots) in 9 out of 16 recipients, compared to 3/8 mice
receiving 10,000 GFP
lo cells and 1/8 mice receiving 4000 GFP
lo
cells. Overall, the 14 cases of reconstitution that were confirmed
by alum carmine staining also represented the top14 final BLI
readings.
Found at: doi:10.1371/journal.pone.0008035.s001 (9.30 MB TIF)
Figure S2 In vitro luciferase assay for sorted mammary epithelial
cells from virgin and parous mice. Mammary epithelial cell
populations were collected based on CD24 and CD29 staining and
lysed for in vitro quantification of luciferase activity. Data shown is
normalized to P4 cells (+/2 SEM). The same pattern of luciferase
activity is seen in virgin and pregnant mice, with the higher
expression of luciferase in unsorted populations as the result of the
higher percentage of luciferase expressing MaSCs in the parous
mice.
Found at: doi:10.1371/journal.pone.0008035.s002 (3.76 MB TIF)
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Figure 7. MaSC kinetics during two consecutive pregnancies.
(A) MaSC activity detected by BLI in a single representative mouse
through two pregnancies. (B) Flow cytometry data from three time
points for mice in their first or second pregnancy. Each data point
represents the average percentage (+/2 SEM) of the mammary gland of
P4 cells from four mice.
doi:10.1371/journal.pone.0008035.g007
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